| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | DMH-1 |
|---|
| Description | Selective inhibitor of bone morphogenic protein (BMP) type-I receptor activin receptor-like kinase 2 (ALK2) receptor (IC50 = 108 nM [Hao et al., 2010] or 12.6 nM [Mohedas et al., 2013] in in vitro kinase assays). Exhibits 6- and 19-fold selectivity for ALK-2 over ALK-1 and ALK-3, respectively, and no significant inhibition of AMPK, ALK5, KDR (VEGFR-2) or PDGFRβ receptors. Blocks BMP4-induced phosphorylation of Smads 1, 5 and 8 in HEK293 cells. Promotes neurogenesis in human induced pluripotent stem cells (iPSCs) when used in combination with SB 431542 (Cat. No. 1614). Purity 98%. MW (observed): 380.44 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline |
|---|
| Gene, Accession, CAS # | CAS: 1206711-16-1 |
|---|
| Catalog # | 4126/10 |
|---|
| Price | |
|---|
| Order / More Info | DMH-1 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 23563587, 23928500, 25579684, 25806427, 26110906, 26215036, 26655496, 27320041 |
|---|
| 產(chǎn)品資料 |
|
|